EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Monocyte-to-HDL Cholesterol Ratio and Complete Blood Count-Derived Inflammatory Markers in Myasthenia Gravis: A Cross-Sectional Case–Control Study

Burak Özaltun iD, Merve Hilal Ceren Akgör iD

Journal of Clinical Medicine · 09.11.2026 · 15 (21) · 8738

DOI: 10.3390/jcm15218738 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.11.2026. Verfasst von Burak Özaltun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ankara Atatürk Sanatorium Training and Research Hospital, 06290 Ankara, Turkey. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: We evaluated the monocyte-to-high-density lipoprotein (HDL) cholesterol ratio (MHR) and complete blood count (CBC)-derived inflammatory ratios in myasthenia gravis (MG).

Methods

In this cross-sectional case–control study, 80 patients with MG and 87 controls were compared. MHR, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and systemic inflammation response index (SIRI) were analyzed with Mann–Whitney U tests, ROC analysis, and multivariable logistic regression with covariates selected using a directed acyclic graph.

Results

MHR was higher in MG (median 0.0091 vs. 0.0058; q < 0.001), as were NLR, PLR, and SIRI, whereas LMR was lower. AUCs were 0.779 (SIRI), 0.774 (LMR), and 0.700 (MHR). Each 0.001-unit increase in MHR was associated with 1.23-fold higher odds of MG (95% confidence interval 1.11–1.38; p < 0.001), and adding MHR to the covariates increased the model area under the curve from 0.752 to 0.823 (p = 0.017; complete-case analysis, p = 0.216), mainly through the monocyte count. No marker correlated with severity (all p > 0.12).

Conclusions

MHR and CBC-derived ratios differed between patients with MG and controls independent of demographic and metabolic covariates, largely reflecting monocyte counts, but were not associated with severity and do not appear suitable for disease monitoring.

Schlagwörter

Stichwörter der Autor:innen

monocyte-to-HDL cholesterol ratiomyasthenia gravisneutrophil-to-lymphocyte ratiosystemic inflammationsystemic inflammation response index

Autor:innen und Institutionen

  • Department of Neurology, Ankara Atatürk Sanatorium Training and Research Hospital, 06290 Ankara, Turkey.

ORCID-Profile: Burak Özaltun, Merve Hilal Ceren Akgör

Zitieren

APA

Özaltun, B., & Akgör, M. H. C. (2026). Monocyte-to-HDL Cholesterol Ratio and Complete Blood Count-Derived Inflammatory Markers in Myasthenia Gravis: A Cross-Sectional Case–Control Study. Journal of Clinical Medicine, 15(21), 8738. https://doi.org/10.3390/jcm15218738

Vancouver

Özaltun B, Akgör MHC. Monocyte-to-HDL Cholesterol Ratio and Complete Blood Count-Derived Inflammatory Markers in Myasthenia Gravis: A Cross-Sectional Case–Control Study. Journal of Clinical Medicine. 2026;15(21):8738. doi:10.3390/jcm15218738

BibTeX
@article{zaltun2026,
  author = {Özaltun, Burak and Akgör, Merve Hilal Ceren},
  title = {Monocyte-to-HDL Cholesterol Ratio and Complete Blood Count-Derived Inflammatory Markers in Myasthenia Gravis: A Cross-Sectional Case–Control Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8738},
  doi = {10.3390/jcm15218738}
}
Kostenlos starten →